BTLA and neoplasm: However, recent studies indicate that the role of BTLA in tumor-resident T cells is complex, as engagement by its ligand HVEM inhibits proliferation and cytokine production but promotes survival of tumor-infiltrating lymphocytes (TILs) (54).